CDIO Cardio Diagnostics Holdings Inc. - Common stock
$1.39
Price · May 20, 2026
Fundamentals as of May 15, 2026
52W Range
$1–$8
6% of range
Analyst Rating
BUY
7 analysts
Price Target
—
P/E (TTM)
—
ROE
—
Net Profit Margin
—
CDIO Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$1.39
Market Cap
—
P/E (TTM)
—
EPS (TTM)
—
Revenue (TTM)
—
Div Yield
—
ROE
—
Debt/Equity
—
52W Range
$1 – $8
CDIO Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Configure
10-Year Performance Revenue, net income, margins and EPS trends
Revenue & Net Income
—
EPS
—
Free Cash Flow
—
Margins
—
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Metric
5Y trend
CDIO
Peer Median
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Metric
5Y trend
CDIO
Peer Median
Financial Health Debt, liquidity, solvency — balance sheet strength
Metric
5Y trend
CDIO
Peer Median
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Metric
5Y trend
CDIO
Peer Median
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Metric
5Y trend
CDIO
Peer Median
CDIO Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
BUY
7 analysts
- Strong Buy 2 28.6%
- Buy 4 57.1%
- Hold 1 14.3%
- Sell 0 0.0%
- Strong Sell 0 0.0%
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
1.3%
| Period | EPS Actual | EPS Est | Surprise |
|---|---|---|---|
| March 31, 2025 | $-0.97 | $-1.84 | 0.87% |
| Dec. 31, 2024 | $-0.30 | $-1.84 | 1.5% |
| Sept. 30, 2024 | $-1.80 | $-3.06 | 1.3% |
| June 30, 2024 | $-1.80 | $-3.37 | 1.6% |
Peer Comparison Key metrics vs sector peers
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| CDIO | — | — | — | — | — | — |
| MBIO | — | -2.5 | — | — | -30.9% | — |
| ENSC | $4M | -0.2 | -2.8% | -200.9% | -294.0% | — |
| AKTX | $26.17B | — | — | — | -64.1% | — |
| BRTX | $10M | -0.7 | -10.3% | -3959.4% | -547.6% | 93.4% |
| REVB | — | — | — | — | — | — |
| GRI | $122.9K | -0.0 | — | — | -256.3% | — |
| ALZN | $5M | -0.5 | — | — | -121.7% | — |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement 15
| Metric | Trend | Q1 2026 | Q1 2025 |
|---|---|---|---|
| Revenue | $2.7K | $940 | |
| R&D Expense | $129.8K | $118.8K | |
| SG&A Expense | $1M | $1M | |
| Operating Expenses | $2M | $2M | |
| Operating Income | $-2M | $-2M | |
| Interest Expense | $3.4K | $4.7K | |
| Interest Income | $118 | $187 | |
| Other Non-op | $-3.3K | $-4.5K | |
| Pretax Income | $-2M | $-2M | |
| Net Income | $-2M | $-2M | |
| EPS (Basic) | $-0.63 | $-0.97 | |
| EPS (Diluted) | $-0.63 | $-0.97 | |
| Shares (Basic) | 2,840,778 | 1,686,144 | |
| Shares (Diluted) | 2,840,778 | 1,686,144 | |
| EBITDA | $-2M | · |
Balance Sheet 17
| Metric | Trend | Q1 2026 | Q1 2025 |
|---|---|---|---|
| Cash & Equivalents | $0 | · | |
| Receivables | $4.3K | · | |
| Prepaid Expense | $663.3K | · | |
| Current Assets | $8M | · | |
| PP&E (Net) | $657.6K | · | |
| Accum. Depreciation | $321.9K | · | |
| Total Assets | $10M | · | |
| Accounts Payable | $123.0K | · | |
| Current Liabilities | $491.4K | · | |
| Capital Leases | $164.5K | · | |
| Total Liabilities | $656.0K | · | |
| Common Stock | $29 | · | |
| Paid-in Capital | $40M | · | |
| Retained Earnings | $-31M | · | |
| Stockholders' Equity | $9M | · | |
| Liabilities + Equity | $10M | · | |
| Shares Outstanding | 2,959,469 | · |
Cash Flow 7
| Metric | Trend | Q1 2026 | Q1 2025 |
|---|---|---|---|
| D&A | $5.5K | $45.4K | |
| Stock-based Comp | $24.7K | $30.6K | |
| Operating Cash Flow | $-2M | $-1M | |
| CapEx | $1.8K | $5.8K | |
| Investing Cash Flow | $-63.7K | $-47.4K | |
| Financing Cash Flow | $4M | $3M | |
| Free Cash Flow | $-2M | · |
Profitability 6
| Metric | Trend | Q1 2026 | Q1 2025 |
|---|---|---|---|
| Operating Margin | -66598.4% | · | |
| Net Margin | -66722.3% | · | |
| Pretax Margin | -66722.3% | · | |
| EBITDA Margin | -66598.4% | · | |
| ROA | -16.4% | · | |
| ROE | -17.6% | · |
Liquidity & Solvency 3
| Metric | Trend | Q1 2026 | Q1 2025 |
|---|---|---|---|
| Current Ratio | 15.8 | · | |
| Quick Ratio | 0.0 | · | |
| Interest Coverage | -519.0 | · |
Efficiency 2
| Metric | Trend | Q1 2026 | Q1 2025 |
|---|---|---|---|
| Asset Turnover | 0.0 | · | |
| Receivables Turnover | 0.4 | · |
Valuation (TTM) 10
| Metric | Trend | Q1 2026 | Q1 2025 |
|---|---|---|---|
| Revenue TTM | $13.9K | · | |
| Net Income TTM | $-7M | · | |
| Market Cap | $6M | · | |
| P/E | -0.5 | · | |
| P/S | 413.7 | · | |
| P/B | 0.6 | · | |
| P / Tangible Book | 0.6 | · | |
| P / Cash Flow | -3.7 | · | |
| P / FCF | -3.7 | · | |
| Earnings Yield | -182.1% | · |
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
My Metrics Your personal watchlist — selected rows from Full Fundamentals
📊
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.